Cone specific promoter for use in gene therapy of retinal degenerative diseases.
about
Vitreal delivery of AAV vectored Cnga3 restores cone function in CNGA3-/-/Nrl-/- mice, an all-cone model of CNGA3 achromatopsiaRetinal Gene Therapy: Current Progress and Future Prospects.Cone-Specific Promoters for Gene Therapy of Achromatopsia and Other Retinal DiseasesPhotoreceptor-targeted gene delivery using intravitreally administered AAV vectors in dogs.Targeting iodothyronine deiodinases locally in the retina is a therapeutic strategy for retinal degeneration.
P2860
Cone specific promoter for use in gene therapy of retinal degenerative diseases.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Cone specific promoter for use in gene therapy of retinal degenerative diseases.
@en
type
label
Cone specific promoter for use in gene therapy of retinal degenerative diseases.
@en
prefLabel
Cone specific promoter for use in gene therapy of retinal degenerative diseases.
@en
P2093
P2860
P1476
Cone specific promoter for use in gene therapy of retinal degenerative diseases
@en
P2093
Frank M Dyka
Renee C Ryals
Sanford L Boye
Shannon E Boye
Vince A Chiodo
P2860
P304
P356
10.1007/978-1-4614-3209-8_87
P407
P577
2014-01-01T00:00:00Z